FNDC3B Antibodies

AND FNDC3B ELISA kits, FNDC3B Proteins

Many biological assays use antibodies to detect FNDC3B, such as Western Blot (WB), ELISA, Flow Cytometry, Immunocytochemistry (IHC). These antibodies can be polyclonal or monoclonal, and react with FNDC3B in Human, Mouse, Rat, and many other animal samples. Boster Bio use mainly mouse and rabbit to develop FNDC3B antibodies...

We validate the specificity of these antibodies to FNDC3B by testing them on tissues known to express FNDC3B positively and negatively. Browse below to find the FNDC3B antibody that suites your experiment. We have 1 of these antibodies and many publications and validation images.

If you cannot find antibodies that fit your needs, contact us for making custom antibodies. We have a full suite of custom antibody services covering from research to diagnostic and therapeutic applications.

Previous: Septin9 Next: MTHFSD

FNDC3B Infographic by Boster Bio

All FNDC3B Products

Filter by Application:

Product

Figures

Specificity

Applications

Price

FNDC3B (NM_022763) Human Over-expression Lysate

FNDC3B Human Over-expression Lysates NM_001135095

Human

$628
Cat # LS064778
20 µg, 100 µg

FNDC3B Overview

Facts about Fibronectin type III domain-containing protein 3B.

FNDC3B 3D structure. Source: alphafold

Fibronectin type III domain-containing protein 3B (FNDC3B)

May be a positive regulator of adipogenesis. .

Gene Information

Human
Gene Name:	FNDC3B
Uniprot:	Q53EP0
Entrez:	64778

Family

Belongs to:

FNDC3 family

Alternative Names

FAD104; fibronectin type III domain containing 3B; FLJ23399; HCV NS5A-binding protein 37; MGC10002; NS5ABP37; PRO4979; UNQ2421/PRO4979/PRO34274; YVTM2421

Molecular Weight

Mass (kDA):
132.888 kDA

Genomic Context


Human

Location:	3q26.31
Sequence:	3; NC_000003.12 (172039578..172401669)

Tissue Specificity

Predominantly expressed in white adipose tissue (WAT) especially in the stromal vascular cells. Expressed in adipocyte differentiable 3T3-L1 cells but not in the non- adipogenic cell line NIH-3T3. Expression increased in the early stage of adipogenesis.